Ccb Principal Asset Management Co Ltd - CCB CSI Brand Name Drug Industry ETF (SHE:159835)

China · Delayed Price · Currency is CNY

0.6750

+0.0030 (0.45%)

At close: Sep 23, 2026

Assets	n/a
Expense Ratio	0.60%
PE Ratio	32.56
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-10.36%

Volume	24,097,900
Open	0.6720
Previous Close	0.6720
Day's Range	0.6700 - 0.6810
52-Week Low	0.5410
52-Week High	0.7660
Beta	0.26
Holdings	n/a
Inception Date	Mar 11, 2021

About 159835

159835.SZ was created on 2021-03-11 by CCB. The fund's investment portfolio concentrates primarily on health care equity. Tightly track the target index, and pursue the minimization of tracking deviation and tracking error. Under normal market conditions, the absolute value of the Fund's daily average tracking deviation should not exceed 0.2%, and the annual tracking error should not exceed 2%.

Asset Class Equity

Category Health Care

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 159835

Provider CCB

Index Tracked CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross

Performance

159835 had a total return of -10.36% in the past year, including dividends. Since the fund's inception, the average annual return has been -7.33%.